Silke Frenz

2PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 21, 2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.

Hardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher

|Jul 05, 2019
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.

Katrin Mestermann, Theodoros Giavridis, Justus Weber

Pageof 1